Amgen (NASDAQ: AMGN) EVP uses 1,593 shares to cover tax obligations

Rhea-AI Filing Summary

Amgen Inc. executive Gordon Murdo reported routine tax-related share dispositions, not open-market sales. On May 2, 2026, he had 1,593 shares of common stock withheld at $329.82 per share to cover tax obligations. Following these transactions, he directly holds 49,462 Amgen shares.

A footnote explains his holdings include 488 Dividend Equivalents tied to unvested Restricted Stock Units under Amgen’s equity incentive plan, which pay out in shares according to the vesting schedule.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Gordon Murdo

Role EVP, Global Commercial Ops

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	830	$329.82	$274K
Tax Withholding	Common Stock	763	$329.82	$252K

Holdings After Transaction: Common Stock — 49,462 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Tax-withheld shares (first transaction): 763 shares Tax-withheld shares (second transaction): 830 shares Total tax-withheld shares: 1,593 shares +3 more

6 metrics

Tax-withheld shares (first transaction) 763 shares Common Stock, code F tax-withholding disposition on May 2, 2026

Tax-withheld shares (second transaction) 830 shares Common Stock, code F tax-withholding disposition on May 2, 2026

Total tax-withheld shares 1,593 shares Sum of two F-code tax-withholding dispositions reported

Reference price per share $329.82 per share Price used for both F-code tax-withholding transactions

Shares held after transactions 49,462 shares Total Amgen common shares directly owned following the second transaction

Dividend Equivalents in holdings 488 DEs Credited to unvested RSUs under Amgen’s 2009 Equity Incentive Plan

Key Terms

tax-withholding disposition, Dividend Equivalents (DEs), Restricted Stock Units, Equity Incentive Plan, +1 more

5 terms

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Dividend Equivalents (DEs) financial

"These shares include 488 Dividend Equivalents (DEs) granted pursuant"

Restricted Stock Units financial

"DEs are credited to the reporting person's unvested Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Equity Incentive Plan financial

"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gordon Murdo

(Last) (First) (Middle)

ONE AMGEN CENTER DRIVE

(Street)

THOUSAND OAKS CALIFORNIA 91320

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Global Commercial Ops

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/02/2026		F		830	D	$329.82	49,462	D
Common Stock	05/02/2026		F		763	D	$329.82	48,699(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares include 488 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

	/s/ Murdo Gordon	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Amgen (AMGN) EVP Gordon Murdo report on this Form 4?

Gordon Murdo reported tax-related share dispositions, not open-market trading. A total of 1,593 Amgen common shares were withheld on May 2, 2026 to satisfy tax liabilities associated with equity compensation, at a reference price of $329.82 per share.

How many Amgen (AMGN) shares were involved in Gordon Murdo’s tax withholding?

Two transactions covered 763 and 830 Amgen common shares, totaling 1,593 shares. These were coded as tax-withholding dispositions, meaning shares were delivered back to the company to pay taxes due on equity awards, rather than being sold on the open market.

Does Gordon Murdo still hold Amgen (AMGN) shares after these transactions?

Yes. After the reported tax-withholding transactions, Gordon Murdo directly holds 49,462 shares of Amgen common stock. This indicates the dispositions represent a relatively small portion of his overall reported holdings, consistent with routine equity compensation-related activity.

What does the tax-withholding code F mean for Amgen (AMGN) insider transactions?

Code F on a Form 4 indicates shares were disposed of to cover taxes or exercise costs, not a voluntary market sale. For Amgen, Gordon Murdo’s 1,593-share disposition reflects shares withheld to satisfy tax liabilities from equity awards, rather than a directional bet on the stock.

What are Dividend Equivalents (DEs) mentioned in Gordon Murdo’s Amgen (AMGN) filing?

The filing notes 488 Dividend Equivalents credited to Murdo’s unvested Restricted Stock Units. These DEs mirror dividends on Amgen stock and are paid out in common shares one-for-one as the RSUs vest, plus a cash amount for any remaining fractional share component.

How are Gordon Murdo’s Amgen (AMGN) equity awards structured in this filing?

His holdings include common shares and 488 Dividend Equivalents tied to unvested RSUs under Amgen’s Second Amended and Restated 2009 Equity Incentive Plan. As those RSUs vest, the associated DEs are settled in Amgen shares, aligning executive compensation with shareholder returns.